© Reuters/DADO RUVIC FILE image: photograph illustration of a vial labelled with the Pfizer-BioNTech coronavirus ailment (COVID-19) vaccine (Reuters) -Pfizer Inc and BioNTech SE stated on Thursday they expect to carry 50 million greater doses of their COVID-19 vaccine to the U.S. government with the aid of April-end, because the country prepares to vaccinate children.
The circulate comes after a panel of out of doors advisers to the U.S. food and Drug Administration voted on Tuesday to advocate its authorization for the vaccine in infants aged 5 to eleven. The company's resolution on the vaccine for the age group is awaited.
If authorized and because of this advised via the U.S. facilities for disorder handle and Prevention's (CDC) advisory panel, the groups mentioned they are expecting to then begin delivery the vaccine automatically, in 10 microgram pediatric doses, as directed by means of the U.S. government.
Video: Trudeau says Pfizer to supply hundreds of thousands of COVID-19 vaccine doses for babies ages 5-eleven as soon as permitted (international news)
Trudeau says Pfizer to give tens of millions of COVID-19 vaccine doses for toddlers a long time 5-eleven as soon as accepted
SHARE
SHARE
TWEET
SHARE
electronic mail
click to expand
UP subsequent
The U.S. govt has so far secured 600 million doses of the vaccine to be used within the country and additional 1 billion doses for donation to low- and reduce-core-profits countries.
The drugmakers spoke of they predict initial scientific trial facts on the vaccine's use in children -- aged 2 to lower than 5 years, and 6 months to below 2 years -- is anticipated within the fourth quarter this yr or early first quarter of 2022.
(Reporting by way of Manojna Maddipatla in Bengaluru; modifying via Shounak Dasgupta and Shinjini Ganguli)
0 Comments